Chignell C F, Motten A G, Buettner G R
Environ Health Perspect. 1985 Dec;64:103-10. doi: 10.1289/ehp.8564103.
Chlorpromazine and several other related phenothiazines are known to cause both phototoxic and photoallergic reactions in the skin and eyes of patients receiving these drugs. While the detailed mechanisms of photosensitization are not known, it is obvious that the first step must be the absorption of light by the drug, its metabolites, or photoproducts, or possibly an induced endogenous chemical. In this review, the free-radical photochemistry of phenothiazines is described, and the evidence for the involvement of photoinduced free radicals in photosensitization is examined. Upon irradiation chlorpromazine yields a variety of free radicals including the corresponding cation radical (via photoionization), the neutral promazinyl radical and a chlorine atom (Cl.) (via homolytic cleavage), and a sulfur-centered peroxy radical. The chlorpromazine cation radical is probably responsible for some of the observed in vitro phototoxic effects of this drug. However, it seems unlikely that the cation radical is involved in phototoxicity in vivo, since photoionization only occurs when chlorpromazine is excited into the S2 level (lambda ex less than 280 nm). The promazinyl radical is a more likely candidate for the phototoxic species both in vivo and in vitro. In addition, this radical can react covalently with proteins and other macromolecules to yield antigens which could be responsible for the photoallergic response to chlorpromazine. Neither oxygen-derived radicals nor singlet oxygen (1O2*), appear to be important in chlorpromazine photosensitization. In contrast, it would seem that promazine-induced phototoxicity may result in part from the generation of superoxide (O2-.).(ABSTRACT TRUNCATED AT 250 WORDS)
已知氯丙嗪及其他几种相关的吩噻嗪类药物会在服用这些药物的患者皮肤和眼睛中引发光毒性和光过敏反应。虽然光致敏的详细机制尚不清楚,但显然第一步必定是药物、其代谢产物或光产物,或者可能是一种诱导产生的内源性化学物质吸收光。在这篇综述中,描述了吩噻嗪类药物的自由基光化学,并研究了光诱导自由基参与光致敏的证据。照射时,氯丙嗪会产生多种自由基,包括相应的阳离子自由基(通过光电离)、中性的丙嗪基自由基和一个氯原子(Cl·)(通过均裂),以及一个以硫为中心的过氧自由基。氯丙嗪阳离子自由基可能是该药物一些体外光毒性作用的原因。然而,阳离子自由基似乎不太可能参与体内光毒性,因为光电离仅在氯丙嗪被激发到S2能级(激发波长小于280nm)时才会发生。丙嗪基自由基在体内和体外都更有可能是光毒性物质。此外,该自由基可与蛋白质和其他大分子发生共价反应,产生可能导致对氯丙嗪光过敏反应的抗原。氧衍生自由基和单线态氧(1O2*)在氯丙嗪光致敏中似乎都不重要。相比之下,丙嗪诱导的光毒性似乎可能部分源于超氧阴离子(O2-·)的产生。(摘要截取自250字)